Stephen E. Gould - Jun 15, 2022 Form 4 Insider Report for Atreca, Inc. (BCEL)

Role
Chief Scientific Officer
Signature
/s/ Courtney Phillips, attorney-in-fact
Stock symbol
BCEL
Transactions as of
Jun 15, 2022
Transactions value $
$0
Form type
4
Date filed
6/17/2022, 05:56 PM
Next filing
Feb 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCEL Employee stock option (right to buy) Award $0 +200K $0.00 200K Jun 15, 2022 Class A Common Stock 200K $1.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares of Class A common stock underlying the Option shall vest on June 15, 2023 and the remainder of the shares of Class A common stock underlying the Option shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.